Raphael Pharmaceutical (RAPH) Non Operating Income (2020 - 2024)
Raphael Pharmaceutical's (RAPH) quarterly Non Operating Income came in at -$1000.0 in Q4 2024, up 91.67% year-on-year from -$521.74 in Q1 2024, and up 85.71% quarter-over-quarter from -$7000.0 in Q3 2024.
Raphael Pharmaceutical (RAPH) Non Operating Income (2020 - 2024) Analysis & Trends
Raphael Pharmaceutical has disclosed Non Operating Income across 5 years of filings, most recently posting -$1000.0 for Q4 2024.
- Non Operating Income for Q4 2024 came in at -$1000.0, up 91.67% year-over-year; the trailing twelve-month figure through Dec 2024 was -$10000.0 (up 16.67% YoY), and the FY2025 annual result was -$34000.0, down 240.0% from the prior year.
- Non Operating Income came in at -$1000.0 for Q4 2024 at Raphael Pharmaceutical, up from -$7000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $7000.0 in Q4 2021 to a low of -$17000.0 in Q3 2022.
- The 5-year median for Non Operating Income is -$3000.0 (2020), against an average of -$3888.9.
- Across the five-year window, Non Operating Income jumped 333.33% in 2021 and sank 1300.0% in 2023, its largest moves.
- Raphael Pharmaceutical's Non Operating Income stood at -$3000.0 in 2020, then surged by 333.33% to $7000.0 in 2021, then sank by 85.71% to $1000.0 in 2022, then tumbled by 1300.0% to -$12000.0 in 2023, then soared by 91.67% to -$1000.0 in 2024.
- The last three Non Operating Income figures came in at -$1000.0 (Q4 2024), -$7000.0 (Q3 2024), and $1000.0 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -216.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 20.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -7.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -504,111.66 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 53.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -13.65 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -23.23 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 5.71 Mn |
| 10 | Raphael Pharmaceutical | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -1,000.00 |
| Sep 30, 2024 | -7,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Mar 31, 2024 | -3,000.00 |
| Dec 31, 2023 | -12,000.00 |
| Sep 30, 2023 | 4,000.00 |
| Jun 30, 2023 | 2,000.00 |
| Mar 31, 2023 | -6,000.00 |
| Dec 31, 2022 | 1,000.00 |
| Sep 30, 2022 | -17,000.00 |
| Jun 30, 2022 | -15,000.00 |
| Mar 31, 2022 | -10,000.00 |
| Dec 31, 2021 | 7,000.00 |
| Sep 30, 2021 | 2,000.00 |
| Jun 30, 2021 | -2,000.00 |
| Mar 31, 2021 | -3,000.00 |
| Dec 31, 2020 | -3,000.00 |
| Sep 30, 2020 | -8,000.00 |